Axe Compute Inc. (AGPU) NASDAQ
9.07
+4.19(+85.86%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
9.07
+4.19(+85.86%)
Currency In USD
Address
91 43rd Street
Pittsburgh, PA 15201
United States of America (the)
Phone
412 432 1500
Website
Sector
Technology
Industry
Software - Infrastructure
Employees
23
First IPO Date
May 03, 2010
| Name | Title | Pay | Year Born |
| Raymond F. Vennare | CEO & Chairman | 525,000 | 1952 |
| Joshua Blacher | Interim Chief Financial Officer | 453,940 | 1973 |
| Arlette H. Uihlein | Senior Vice President of Translational Medicine & Drug Discovery and Medical Director | 0 | N/A |
| Thomas McLaughlin | Chief Investment Officer | 0 | N/A |
| Lawrence J. DeLucas | Senior Vice President of Biologics | 0 | N/A |
| Arlette H. Uihlein | Senior VP of Translational Medicine & Drug Discovery and Medical Director | 0 | N/A |
| Sara Turken | Senior VP & General Counsel | 0 | N/A |
Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.